US and Irish Researchers Launch Study on Alzheimer's Drug
Posted on: Thursday, 21 September 2006, 12:01 CDT
The Roskamp Institute in Florida and Trinity College in Ireland have launched a clinical study to test new research on the protein amyloid that could lead to a potential breakthrough treatment for Alzheimer's.
The study will focus on the hypertension drug Nilvadipine, which has been found to decrease levels of amyloid in the brain. It is the presence of amyloid in the brain that is believed to cause the onset of Alzheimer's. The drug was also found to increase the flow of blood to the brain, which is believed to be beneficial in the treatment of the disease.
If the trial is successful the treatment could change the direction of other studies of dementia.
The clinical study itself will be conducted in Ireland at Trinity College and several supporting studies will be conducted in Florida.
"As scientists, we are always cautious when testing new drug therapies and are careful not to unrealistically raise expectations and hopes too high. The road to finding a cure for Alzheimer's disease is a long one, but it is our hope that the research gained through this study will put us one step closer to that ultimate goal," stated Dr Michael Mullan, Roskamp Institute's executive director.
The Roskamp Institute is focused on understanding causes of and finding cures for diseases of the mind such as neuropsychiatric and neurodegenerative disorders and addictions.
Source: Datamonitor
Related Articles
- Roskamp Institute Announces Enrollment of First Students to Participate in its Innovative Research Doctorate Program
- Roskamp Institute's Associate Clinic Director Named Chairperson of the Alzheimer's Disease Initiative Advisory Committee
- Roskamp Institute Wins Grant for Lung Cancer Research
- Sarasota's Roskamp Institute Highlights Positive Japanese Data That Validates Its Ongoing Alzheimer's Disease Research
- Sarasota's Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
- Sarasota's Roskamp Institute Announces Positive Safety Data in Human Clinical Study for Alzheimer's Disease
- Sarasota's Roskamp Institute Announces Participation in Multiple Sclerosis Study
- Roskamp Institute Marks World Alzheimer's Day By Announcing the Launch of Major Clinical Study on Promising New Alzheimer's Treatment
- Brookside Institute Advances Treatment of Drug and Alcohol Abuse With Science-Based Programs
- Study: No Good Drug Therapies for Dementia Symptoms
 |
 |
User Comments (0)
RSS Feeds